David Judson has been appointed vice president and chief compliance officer at bioRASI. Mr. Judson will lead the company’s expansion efforts for worldwide operations and its strengthening of centralized Compliance, QA, Audit and Training infrastructure.
“We are extremely pleased to bring David Judson to lead our Compliance and Audit services branch,” said Dr. Boris Reznik, chairman of bioRASI. “Our acquaintance with David started six years ago when he conducted a sponsor audit of bioRASI. From the very beginning it was clear that we share similar views on the role and importance of quality functions at a CRO. As bioRASI's quality infrastructure has expanded, it became essential to add the compliance officer of David's caliber to our team.”
Prior to joining the company, Mr. Judson spent more than 25 years in leading compliance functions at big and small pharma companies, as well as CROs. Mr. Judson’s quality-focused experience covers R&D discovery, preclinical (GLP), Phase I-IV (GCP), clinical packaging, and pharmaceutical manufacturing (GMP and ISO 9000). He has conducted more than 1,500 audits in more than 25 countries.